Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia

被引：5
|
作者：
Cafforio, Luciana [1 ]
Raponi, Sara [1 ]
Cappelli, Luca Vincenzo [1 ]
Ilari, Caterina [1 ]
Soscia, Roberta [1 ]
De Propris, Maria Stefania [1 ]
Mariglia, Paola [1 ]
Rigolin, Gian Matteo [2 ]
Bardi, Antonella [2 ]
Peragine, Nadia
Piciocchi, Alfonso [3 ]
Arena, Valentina [3 ]
Mauro, Francesca Romana [1 ]
Cuneo, Antonio
Guarini, Anna [4 ]
Foa, Robin [1 ]
Del Giudice, Ilaria [1 ]
机构：
[1] Sapienza Univ, Hematol Sect, Dept Translat & Precis Med, Rome, Italy
[2] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Dept Med Sci, Hematol Sect, Ferrara, Italy
[3] GIMEMA Fdn, GIMEMA Data Ctr, Rome, Italy
[4] Sapienza Univ, Dept Mol Med, Rome, Italy
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 01期
关键词：
CLINICAL IMPACT; RESISTANCE; MUTATIONS;
D O I：
10.3324/haematol.2020.263715
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：334 / 337
页数：4
相关论文
共 50 条
  • [21] Telomere status in chronic lymphocytic leukemia with TP53 disruption
    Guieze, Romain
    Pages, Melanie
    Veronese, Lauren
    Combes, Patricia
    Lemal, Richard
    Gay-Bellile, Mathilde
    Chauvet, Martine
    Callanan, Mary
    Kwiatkowski, Fabrice
    Pereira, Bruno
    Vago, Philippe
    Bay, Jacques-Olivier
    Tournilhac, Olivier
    Tchirkov, Andrei
    ONCOTARGET, 2016, 7 (35) : 56976 - 56985
  • [22] The role of TP53 network in the pathogenesis of chronic lymphocytic leukemia
    Wang, Cheng
    Wang, Xin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (07): : 1223 - 1229
  • [23] Chronic Lymphocytic Leukemia With TP53 Aberrations: Breakthroughs and Challenges
    Edenhofer, Simone A.
    Stilgenbauer, Stephan
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (06) : 381 - +
  • [24] TP53 MUTATIONS ARE EARLY EVENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) DISEASE PROGRESSION AND PRECEDE CLONAL EVOLUTION TO COMPLEX KARYOTYPES
    Baran-Marszak, F.
    Lazarian, G.
    Tausch, E.
    Sebaa, A.
    Bianchi, V.
    Eclache, V.
    Letestu, R.
    Stilgenbauer, S.
    Cymbalista, F.
    HAEMATOLOGICA, 2015, 100 : 223 - 223
  • [25] DEEP SEQUENCING IDENTIFIES TP53 MUTATIONS BEFORE THEIR CLONAL SELECTION BY THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Trbusek, M.
    Stano-Kozubik, K.
    Malcikova, J.
    Smardova, J.
    Sebejova, L.
    Doubek, M.
    Brychtova, Y.
    Svitakova, M.
    Pavlova, S.
    Mraz, M.
    Plevova, K.
    Vranova, V.
    Tom, N.
    Mayer, J.
    Pospisilova, S.
    Tichy, B.
    HAEMATOLOGICA, 2012, 97 : 234 - 234
  • [26] TP53 Mutations and Other Cell-Intrinsic Determinants of the Apoptotic Response to Ibrutinib in Chronic Lymphocytic Leukemia
    Amin, Nisar A.
    Balasubramanian, Sriram
    Saiya-Cork, Kamlai
    Malek, Sami N.
    BLOOD, 2015, 126 (23)
  • [27] Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study
    Riccardo Bomben
    Francesca Maria Rossi
    Filippo Vit
    Tamara Bittolo
    Antonella Zucchetto
    Robel Papotti
    Erika Tissino
    Federico Pozzo
    Massimo Degan
    Jerry Polesel
    Pietro Bulian
    Roberto Marasca
    Gianluigi Reda
    Luca Laurenti
    Jacopo Olivieri
    Annalisa Chiarenza
    Roberta Laureana
    Massimiliano Postorino
    Maria Ilaria Del Principe
    Antonio Cuneo
    Massimo Gentile
    Fortunato Morabito
    Gilberto Fronza
    Agostino Tafuri
    Francesco Zaja
    Robin Foà
    Francesco Di Raimondo
    Giovanni Del Poeta
    Valter Gattei
    Leukemia, 2023, 37 : 914 - 918
  • [28] Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study
    Bomben, Riccardo
    Rossi, Francesca Maria
    Vit, Filippo
    Bittolo, Tamara
    Zucchetto, Antonella
    Papotti, Robel
    Tissino, Erika
    Pozzo, Federico
    Degan, Massimo
    Polesel, Jerry
    Bulian, Pietro
    Marasca, Roberto
    Reda, Gianluigi
    Laurenti, Luca
    Olivieri, Jacopo
    Chiarenza, Annalisa
    Laureana, Roberta
    Postorino, Massimiliano
    Del Principe, Maria Ilaria
    Cuneo, Antonio
    Gentile, Massimo
    Morabito, Fortunato
    Fronza, Gilberto
    Tafuri, Agostino
    Zaja, Francesco
    Foa, Robin
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    LEUKEMIA, 2023, 37 (04) : 914 - 918
  • [29] TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
    Lazarian, Gregory
    Theves, Floriane
    Hormi, Myriam
    Letestu, Remi
    Eclache, Virginie
    Bidet, Audrey
    Cornillet-Lefebvre, Pascale
    Davi, Frederic
    Delabesse, Eric
    Estienne, Marie-Helene
    Etancelin, Pascaline
    Kosmider, Olivier
    Laibe, Sophy
    Lode, Laurence
    Muller, Marc
    Nadal, Nathalie
    Naguib, Dina
    Pastoret, Cedric
    Poulain, Stephanie
    Sujobert, Pierre
    Veronese, Lauren
    Imache, Samia
    Lefebvre, Valerie
    Cymbalista, Florence
    Baran-Marszak, Fanny
    Soussi, Thierry
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E159 - E162
  • [30] Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia
    Trbusek, Martin
    Malcikova, Jitka
    Mayer, Jiri
    LEUKEMIA RESEARCH, 2011, 35 (07) : 981 - 982
12345